860 related articles for article (PubMed ID: 17047030)
1. Activation of mouse and human peroxisome proliferator-activated receptors (alpha, beta/delta, gamma) by perfluorooctanoic acid and perfluorooctane sulfonate.
Takacs ML; Abbott BD
Toxicol Sci; 2007 Jan; 95(1):108-17. PubMed ID: 17047030
[TBL] [Abstract][Full Text] [Related]
2. Evaluating the additivity of perfluoroalkyl acids in binary combinations on peroxisome proliferator-activated receptor-α activation.
Wolf CJ; Rider CV; Lau C; Abbott BD
Toxicology; 2014 Feb; 316():43-54. PubMed ID: 24374136
[TBL] [Abstract][Full Text] [Related]
3. Transcription of genes involved in fat metabolism in chicken embryos exposed to the peroxisome proliferator-activated receptor alpha (PPARα) agonist GW7647 or to perfluorooctane sulfonate (PFOS) or perfluorooctanoic acid (PFOA).
Strömqvist M; Olsson JA; Kärrman A; Brunström B
Comp Biochem Physiol C Toxicol Pharmacol; 2012 Jun; 156(1):29-36. PubMed ID: 22465071
[TBL] [Abstract][Full Text] [Related]
4. Activation of mouse and human peroxisome proliferator-activated receptor alpha by perfluoroalkyl acids of different functional groups and chain lengths.
Wolf CJ; Takacs ML; Schmid JE; Lau C; Abbott BD
Toxicol Sci; 2008 Nov; 106(1):162-71. PubMed ID: 18713766
[TBL] [Abstract][Full Text] [Related]
5. Peroxisome proliferator-activated receptor (PPAR)-gamma positively controls and PPARalpha negatively controls cyclooxygenase-2 expression in rat brain astrocytes through a convergence on PPARbeta/delta via mutual control of PPAR expression levels.
Aleshin S; Grabeklis S; Hanck T; Sergeeva M; Reiser G
Mol Pharmacol; 2009 Aug; 76(2):414-24. PubMed ID: 19483106
[TBL] [Abstract][Full Text] [Related]
6. trans-activation of PPARalpha and induction of PPARalpha target genes by perfluorooctane-based chemicals.
Shipley JM; Hurst CH; Tanaka SS; DeRoos FL; Butenhoff JL; Seacat AM; Waxman DJ
Toxicol Sci; 2004 Jul; 80(1):151-60. PubMed ID: 15071170
[TBL] [Abstract][Full Text] [Related]
7. Differential activation of nuclear receptors by perfluorinated fatty acid analogs and natural fatty acids: a comparison of human, mouse, and rat peroxisome proliferator-activated receptor-alpha, -beta, and -gamma, liver X receptor-beta, and retinoid X receptor-alpha.
Vanden Heuvel JP; Thompson JT; Frame SR; Gillies PJ
Toxicol Sci; 2006 Aug; 92(2):476-89. PubMed ID: 16731579
[TBL] [Abstract][Full Text] [Related]
8. The role of mouse and human peroxisome proliferator-activated receptor-α in modulating the hepatic effects of perfluorooctane sulfonate in mice.
Su S; Billy LJ; Chang S; Gonzalez FJ; Patterson AD; Peters JM
Toxicology; 2022 Jan; 465():153056. PubMed ID: 34861291
[TBL] [Abstract][Full Text] [Related]
9. Developmental toxicity of perfluorooctane sulfonate (PFOS) is not dependent on expression of peroxisome proliferator activated receptor-alpha (PPAR alpha) in the mouse.
Abbott BD; Wolf CJ; Das KP; Zehr RD; Schmid JE; Lindstrom AB; Strynar MJ; Lau C
Reprod Toxicol; 2009 Jun; 27(3-4):258-265. PubMed ID: 18595657
[TBL] [Abstract][Full Text] [Related]
10. Immunotoxicity of perfluorooctanoic acid and perfluorooctane sulfonate and the role of peroxisome proliferator-activated receptor alpha.
DeWitt JC; Shnyra A; Badr MZ; Loveless SE; Hoban D; Frame SR; Cunard R; Anderson SE; Meade BJ; Peden-Adams MM; Luebke RW; Luster MI
Crit Rev Toxicol; 2009; 39(1):76-94. PubMed ID: 18802816
[TBL] [Abstract][Full Text] [Related]
11. Multiplicity of nuclear receptor activation by PFOA and PFOS in primary human and rodent hepatocytes.
Bjork JA; Butenhoff JL; Wallace KB
Toxicology; 2011 Oct; 288(1-3):8-17. PubMed ID: 21723365
[TBL] [Abstract][Full Text] [Related]
12. Gene expression profiling in the liver and lung of perfluorooctane sulfonate-exposed mouse fetuses: comparison to changes induced by exposure to perfluorooctanoic acid.
Rosen MB; Schmid JE; Das KP; Wood CR; Zehr RD; Lau C
Reprod Toxicol; 2009 Jun; 27(3-4):278-288. PubMed ID: 19429403
[TBL] [Abstract][Full Text] [Related]
13. Evidence for the involvement of xenobiotic-responsive nuclear receptors in transcriptional effects upon perfluoroalkyl acid exposure in diverse species.
Ren H; Vallanat B; Nelson DM; Yeung LWY; Guruge KS; Lam PKS; Lehman-McKeeman LD; Corton JC
Reprod Toxicol; 2009 Jun; 27(3-4):266-277. PubMed ID: 19162173
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of perfluoroalkyl acid activity using primary mouse and human hepatocytes.
Rosen MB; Das KP; Wood CR; Wolf CJ; Abbott BD; Lau C
Toxicology; 2013 Jun; 308():129-37. PubMed ID: 23567314
[TBL] [Abstract][Full Text] [Related]
15. Effects of perfluorooctanoic acid (PFOA) on expression of peroxisome proliferator-activated receptors (PPAR) and nuclear receptor-regulated genes in fetal and postnatal CD-1 mouse tissues.
Abbott BD; Wood CR; Watkins AM; Tatum-Gibbs K; Das KP; Lau C
Reprod Toxicol; 2012 Jul; 33(4):491-505. PubMed ID: 22154759
[TBL] [Abstract][Full Text] [Related]
16. Enhanced cytotoxicity of pentachlorophenol by perfluorooctane sulfonate or perfluorooctanoic acid in HepG2 cells.
Shan G; Ye M; Zhu B; Zhu L
Chemosphere; 2013 Nov; 93(9):2101-7. PubMed ID: 23972907
[TBL] [Abstract][Full Text] [Related]
17. PPARα-independent transcriptional targets of perfluoroalkyl acids revealed by transcript profiling.
Rosen MB; Das KP; Rooney J; Abbott B; Lau C; Corton JC
Toxicology; 2017 Jul; 387():95-107. PubMed ID: 28558994
[TBL] [Abstract][Full Text] [Related]
18. In vitro evaluation of the immunotoxic potential of perfluorinated compounds (PFCs).
Corsini E; Avogadro A; Galbiati V; dell'Agli M; Marinovich M; Galli CL; Germolec DR
Toxicol Appl Pharmacol; 2011 Jan; 250(2):108-16. PubMed ID: 21075133
[TBL] [Abstract][Full Text] [Related]
19. Perfluorinated chemicals, PFOS and PFOA, enhance the estrogenic effects of 17β-estradiol in T47D human breast cancer cells.
Sonthithai P; Suriyo T; Thiantanawat A; Watcharasit P; Ruchirawat M; Satayavivad J
J Appl Toxicol; 2016 Jun; 36(6):790-801. PubMed ID: 26234195
[TBL] [Abstract][Full Text] [Related]
20. Developmental exposure to perfluorooctane sulfonate (PFOS) and perfluorooctanoic acid (PFOA) selectively decreases brain dopamine levels in Northern leopard frogs.
Foguth RM; Flynn RW; de Perre C; Iacchetta M; Lee LS; Sepúlveda MS; Cannon JR
Toxicol Appl Pharmacol; 2019 Aug; 377():114623. PubMed ID: 31195004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
